Matthew Buten
Chief Financial OfficerMr. Matthew Buten, also known as Matt, served as Director at Artizan Biosciences, Inc. since 2022. He serves as Chief Financial Officer at Biohaven Ltd. He was a Chief Financial Officer at Biohaven Pharmaceutical Holding Company Ltd. since December 15, 2021 until October 03, 2022 and had been its Director until October 03, 2022. Mr. Buten previously served as Managing Director of Foresite Capital Management from December 2012 to December 2021. Prior to joining Foresite Capital Management, Mr. Buten served as a healthcare portfolio Manager at Catapult Capital Management LLC / Millennium LP from June 2007 to June 2012. Prior to joining Millennium in mid-2007, Mr. Buten was Co-Founder and Co-Manager of Sapphire Capital, where he focused on medical technology, diagnostics, life science tools suppliers, diagnostic services and healthcare information technology. From 2000 to 2005 Mr. Buten was an Equity Analyst for Argus Partners and its predecessor, where he focused on medical technology. He also has investment banking experience at Kidder Peabody, Smith Barney and Needham, most recently running the healthcare banking effort with a focus on mergers and acquisitions, equity and debt financings and spin-offs. Prior to Argus, Mr. Buten served as a Managing Director and Head of Healthcare Investment Banking for Needham and Company. At Needham, he also sourced healthcare venture capital opportunities for their venture capital fund, Needham Capital Partners. Prior to joining Needham in 1996, Mr. Buten worked at Smith Barney as a Director in the Investment Banking division. He serves as a Director of Sotera Wireless, Inc. Mr. Buten has experience as a healthcare Investor and investment banking advising and structuring deals for both small and large capitalization companies. Mr. Buten received his B.S. in Economics from the The Wharton School of the University of Pennsylvania in 1983 with a concentration in Corporate Finance.
Positions
- Company NameBiohaven Ltd.Stock CodeBHVNPositionChief Financial OfficerColleagues
- VCVladimir CoricChairman & CEO
- KGKimberly GentileSenior Vice President of Clinical Operations
- BDBruce D. CarChief Innovation Officer
- DYDeb YoungSenior Director of Regulatory Affairs & Operations
- DGDouglas GrayCorporate Secretary & Director
- MTMichael Thomas HeffernanLead Independent Director
- GHGregory H. BaileyIndependent Director
- JWJohn Winston ChildsIndependent Director
